Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

CONCLUSION: HP/TAZ lotion provides therapeutic effects that persist after treatment cessation, supporting its use in long-term management of plaque psoriasis.PMID:34130581 | DOI:10.1080/09546634.2021.1914310

Source: Journal of Dermatological Treatment - June 16, 2021 Category: Dermatology Authors: Mark G Lebwohl Linda Stein Gold James Q Del Rosso Lawrence Green Abby Jacobson Source Type: research